We are directly involved in lung cancer research across the continuum of care but with a special focus on early detection/intervention and lung cancer survivorship. If you are interested in partnering with GO2 Foundation for Lung Cancer on a research study, please contact our Senior Director of Science and Research, Jennifer King. Some of the projects we are currently partnering on include:
Studying optimal smoking cessation during lung cancer screening.
A study for patients with ALK drug resistance.
ROS1 PDX Study
Making models of ROS1-fusion positive tumors.
ROS1 Cell Line Study
ROS1-Fusion positive specimens for cell lines initiative.
EGFR PDX Study
Making models of EGFR positive tumors.
Genomics of Young Lung Cancer
Studying lung cancer in people under 40.
Understanding physician communication to decrease stigma.
Supporting development of a blood test for early cancer detection.
Studying public perception of lung cancer over the past decade.
Needs of Long Term Survivors
Understanding the unique needs of patients more than five years after diagnosis.
GIVE A SCAN®
The world’s first patient-powered open access database for lung cancer research.
Comparing surgery or stereotactic radiotherapy in early lung cancer.
Master protocol to help patients find the best treatments.
Maine LungCAPs Initiative
Improving prevention and screening statewide in Maine.